MSLN and ovarian neoplasm: More abundant transcripts in LGSC-PT included the CA-125 binding partner mesothelin (MSLN) and the serine protease KLK6, which predicts the recurrence of borderline and low-grade ovarian tumors and is regulated by MAPK29.